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Conclusion: An important influencing factor remains vicinity 
to the OAR. It is possible to achieve falloff rates of 100-80% 
within a distance of 2 mm and a 100% to 50% fall within 7 
mm. This data can help enable select patients for upfront STS 
versus fractionated SRT during initial assessment of patients.  
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Purpose or Objective: To compare and analyze the 
characteristics of static intensity-modulated radiotherapy(s-
IMRT) versus constant dose rate and constant angle speed 
intensity modulated arc therapy(c-IMAT) in the treatment of 
upper thoracic and cervical esophagus cancer. By Delta4 
verified the commissioning of c-IMAT implementation in the 
Varian Clinical 23IX accelerator. 
 
Material and Methods: Eleven esophageal neoplasms patients 
treated with step-and-shoot s-IMRT at our hospital, were 
replannedusing c-IMAT. The plans were generated with 
Oncentra ver4.1 planning system, PTV were prescribed to 60 
Gy in 30 fractions. Planning objectives for PTV corresponding 
with the IMRT plans，were at least 95% planning target 
volumereached the prescription dose and V110 no more than 
10％．The maximum dose of spinal-cord was constrained 
below 45 Gy. Pared-sample T-test were applied to dose 
volume values for PTV and OAR from DVH． 
 
Results: There were no significant differences between s-
IMRT and c-IMAT in 
PTVmin，D90，D95，D98，V90，V95，V100，V105，V110，D
max or total lung V10，V20，V25，V30 and average lung dose 
(all P>0.05)．However, the differences were significant in 
terms of D2, D50, V105, PTVaverage, HI and CI of PTV，V5 
and V15 of the total lung (all P<0.05)(see table1 and 
figure1)．And treatment times were reduced significantly 
with c-IMAT(81s vs. 238.4s, p < 0.05), while, MU increased by 
a factor of 1.2, s-IMRT is 513.5MU versus c-IMAT is 624.1 MU 
(P=0.000). For the gamma Index (±3%, ±3mm), the s-IMRT 
(94.0±0.9 %) is higher than c-IMAT(91.9±1.1%), but all can 







Conclusion: In Varian Clinical 23IX accelerator designed c- 
IMAT plan can achieve similar or better dosimetry with s-
IMRT, having better PTV homogeneity and conformal index, 
much less treatment time advantage, and so the c- IMAT plan 
can be implemented smoothly and quickly into a busy cancer 
center, but the total MU and the average does of lung 
increased compared with s-IMRT.Hence in the treatment of 
upper thoracic and cervical esophagus cancer patients an 
evaluation of weight loss must be performed during 
treatment for C-IMAT. 
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Purpose or Objective: 
Introduction Postoperative endometrial carcinoma patients 
with large volume of target area and the shape of the target 
area is concave, treatment with IMRT is time 
consuming.Treated with VMAT can produce similar or better 
dose distributions, also can reduce treatment time and the 
monitor units (MU)[1,2]. However, VMAT can only be 
implemented on the new generation accelerators such as the 
Varian RapidArc and Elekta Synergy, which prevents most 
existing linacs from delivering in VMAT. R Zhang et al.[3] had 
been proposed an alternative planning approach for VMAT 
using constant dose-rate and constant gantry speed arc 
therapy (CDR-CAS-IMAT) implementation on Varian 23EX for 
thoracic esophageal carcinoma, the results showing that the 
treatment times compared with the IMRT technology were 
decresed significantly can be reached to 62.9%.  
Objective The purpose of this study is to investigate using 
CDR-CAS-IMAT on Varian 23IX, by comparing with the IMRT to 
evaluate the performance of CDR-CAS-IMAT on postoperative 
endometrial carcinoma patients and then provide guidance 
for clinical treatment.  
 
Material and Methods: 30 postoperative endometrial 
carcinoma patients treated with IMRT on Varian 23IX were 
replanted using CDR-CAS-IMAT. The plans were generated on 
Oncentra v4.1 planning system, PTV was prescribed to 50.4 
